Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Acute Leukemias - Persistent Unmet Needs Confer Significant Commercial Opportunity' returned 2 results - Page 1 of 1   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Pipeline Insight: Small Molecule Targeted Cancer Therapies - New targets set to drive growth   Datamonitor, April 2010, Pages: 243 of the current small molecule targeted cancer therapies pipeline by developmental phase, drug target and company -Insight and analysis of market potential including commercial opportunity and discussion of unmet Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of First Approval set to Reinvigorate Interest from Major Companies   Datamonitor, Dec 2009, Pages: 174 including commercial opportunity, unmet needs and patient potential Highlights of this title The theoretical market potential for therapeutic cancer vaccines in the seven major markets totals over $4 Results:  First -   Prev -   1 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets1    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network